nodes	percent_of_prediction	percent_of_DWPC	metapath
Loxapine—HTR1D—meninx—sarcoma	0.0605	0.139	CbGeAlD
Loxapine—HTR1B—dura mater—sarcoma	0.0575	0.132	CbGeAlD
Loxapine—HTR1D—dura mater—sarcoma	0.0557	0.128	CbGeAlD
Loxapine—CHRM3—muscle of abdomen—sarcoma	0.0235	0.0539	CbGeAlD
Loxapine—HTR7—pulmonary artery—sarcoma	0.0189	0.0435	CbGeAlD
Loxapine—HRH4—hematopoietic system—sarcoma	0.0136	0.0313	CbGeAlD
Loxapine—HTR2A—pulmonary artery—sarcoma	0.0118	0.0271	CbGeAlD
Loxapine—HTR1E—myometrium—sarcoma	0.0093	0.0214	CbGeAlD
Loxapine—HRH4—bone marrow—sarcoma	0.00875	0.0201	CbGeAlD
Loxapine—HTR2A—hindlimb—sarcoma	0.00714	0.0164	CbGeAlD
Loxapine—HTR2A—appendage—sarcoma	0.00613	0.0141	CbGeAlD
Loxapine—DRD5—hematopoietic system—sarcoma	0.0061	0.014	CbGeAlD
Loxapine—HTR7—endothelium—sarcoma	0.00593	0.0136	CbGeAlD
Loxapine—HRH2—hematopoietic system—sarcoma	0.00573	0.0132	CbGeAlD
Loxapine—DRD4—testis—sarcoma	0.00507	0.0117	CbGeAlD
Loxapine—HRH2—skin of body—sarcoma	0.00498	0.0114	CbGeAlD
Loxapine—CHRM5—skin of body—sarcoma	0.00476	0.0109	CbGeAlD
Loxapine—HTR3A—hematopoietic system—sarcoma	0.0045	0.0103	CbGeAlD
Loxapine—HRH2—cardiac atrium—sarcoma	0.00435	0.00999	CbGeAlD
Loxapine—DRD5—lymphoid tissue—sarcoma	0.00429	0.00986	CbGeAlD
Loxapine—CHRM4—testis—sarcoma	0.00384	0.00881	CbGeAlD
Loxapine—SLC6A3—hematopoietic system—sarcoma	0.00375	0.0086	CbGeAlD
Loxapine—HTR2A—endothelium—sarcoma	0.0037	0.00849	CbGeAlD
Loxapine—HTR1D—connective tissue—sarcoma	0.00352	0.00808	CbGeAlD
Loxapine—SLC6A4—hematopoietic system—sarcoma	0.00343	0.00788	CbGeAlD
Loxapine—ADRB1—connective tissue—sarcoma	0.00342	0.00786	CbGeAlD
Loxapine—ADRA2C—myometrium—sarcoma	0.00312	0.00716	CbGeAlD
Loxapine—HTR1A—hematopoietic system—sarcoma	0.00305	0.007	CbGeAlD
Loxapine—HRH2—liver—sarcoma	0.00297	0.00682	CbGeAlD
Loxapine—HTR7—hematopoietic system—sarcoma	0.00291	0.00669	CbGeAlD
Loxapine—ADRA2C—seminal vesicle—sarcoma	0.00282	0.00647	CbGeAlD
Loxapine—ADRA1A—hematopoietic system—sarcoma	0.00281	0.00645	CbGeAlD
Loxapine—HTR7—connective tissue—sarcoma	0.0028	0.00644	CbGeAlD
Loxapine—ADRB1—cardiac atrium—sarcoma	0.0027	0.00619	CbGeAlD
Loxapine—CHRM3—smooth muscle tissue—sarcoma	0.0027	0.00619	CbGeAlD
Loxapine—Mediastinal disorder—Thiotepa—sarcoma	0.0026	0.00542	CcSEcCtD
Loxapine—Agranulocytosis—Mitoxantrone—sarcoma	0.00259	0.0054	CcSEcCtD
Loxapine—Dysphagia—Etoposide—sarcoma	0.00259	0.0054	CcSEcCtD
Loxapine—HTR7—smooth muscle tissue—sarcoma	0.00257	0.00589	CbGeAlD
Loxapine—Alopecia—Thiotepa—sarcoma	0.00255	0.00532	CcSEcCtD
Loxapine—Bronchospasm—Etoposide—sarcoma	0.00255	0.00531	CcSEcCtD
Loxapine—Hypoaesthesia—Vincristine—sarcoma	0.00255	0.00531	CcSEcCtD
Loxapine—Liver injury—Doxorubicin—sarcoma	0.00255	0.00531	CcSEcCtD
Loxapine—Alopecia—Dactinomycin—sarcoma	0.00253	0.00528	CcSEcCtD
Loxapine—HRH1—myometrium—sarcoma	0.00253	0.00582	CbGeAlD
Loxapine—Hepatitis—Mitoxantrone—sarcoma	0.0025	0.0052	CcSEcCtD
Loxapine—ADRA2A—myometrium—sarcoma	0.00249	0.00571	CbGeAlD
Loxapine—Tension—Thiotepa—sarcoma	0.00247	0.00514	CcSEcCtD
Loxapine—Dyskinesia—Epirubicin—sarcoma	0.00247	0.00514	CcSEcCtD
Loxapine—Dysarthria—Epirubicin—sarcoma	0.00245	0.0051	CcSEcCtD
Loxapine—Amenorrhoea—Doxorubicin—sarcoma	0.00244	0.00508	CcSEcCtD
Loxapine—Gait disturbance—Epirubicin—sarcoma	0.00237	0.00494	CcSEcCtD
Loxapine—Vision blurred—Thiotepa—sarcoma	0.00237	0.00494	CcSEcCtD
Loxapine—Angiopathy—Vincristine—sarcoma	0.00232	0.00484	CcSEcCtD
Loxapine—Hepatocellular injury—Epirubicin—sarcoma	0.00232	0.00483	CcSEcCtD
Loxapine—Agitation—Thiotepa—sarcoma	0.00231	0.00482	CcSEcCtD
Loxapine—Mediastinal disorder—Vincristine—sarcoma	0.00231	0.00481	CcSEcCtD
Loxapine—Dyskinesia—Doxorubicin—sarcoma	0.00228	0.00475	CcSEcCtD
Loxapine—HRH2—lymph node—sarcoma	0.00228	0.00523	CbGeAlD
Loxapine—Renal failure—Etoposide—sarcoma	0.00227	0.00473	CcSEcCtD
Loxapine—Dysarthria—Doxorubicin—sarcoma	0.00227	0.00472	CcSEcCtD
Loxapine—Alopecia—Vincristine—sarcoma	0.00226	0.00472	CcSEcCtD
Loxapine—Jaundice—Etoposide—sarcoma	0.00225	0.00469	CcSEcCtD
Loxapine—Leukopenia—Thiotepa—sarcoma	0.00225	0.00469	CcSEcCtD
Loxapine—Salivary hypersecretion—Epirubicin—sarcoma	0.00225	0.00469	CcSEcCtD
Loxapine—ADRA2A—seminal vesicle—sarcoma	0.00225	0.00516	CbGeAlD
Loxapine—Leukopenia—Dactinomycin—sarcoma	0.00223	0.00466	CcSEcCtD
Loxapine—Alopecia—Mitoxantrone—sarcoma	0.00221	0.00459	CcSEcCtD
Loxapine—Gait disturbance—Doxorubicin—sarcoma	0.0022	0.00458	CcSEcCtD
Loxapine—Cough—Thiotepa—sarcoma	0.00219	0.00457	CcSEcCtD
Loxapine—Convulsion—Thiotepa—sarcoma	0.00218	0.00454	CcSEcCtD
Loxapine—HRH1—hematopoietic system—sarcoma	0.00217	0.00499	CbGeAlD
Loxapine—Hypertension—Thiotepa—sarcoma	0.00217	0.00452	CcSEcCtD
Loxapine—Agranulocytosis—Etoposide—sarcoma	0.00216	0.00449	CcSEcCtD
Loxapine—Hepatocellular injury—Doxorubicin—sarcoma	0.00214	0.00447	CcSEcCtD
Loxapine—Dry eye—Epirubicin—sarcoma	0.00214	0.00446	CcSEcCtD
Loxapine—ADRA2A—hematopoietic system—sarcoma	0.00214	0.0049	CbGeAlD
Loxapine—Dysgeusia—Mitoxantrone—sarcoma	0.00213	0.00443	CcSEcCtD
Loxapine—HRH1—connective tissue—sarcoma	0.00209	0.00481	CbGeAlD
Loxapine—Salivary hypersecretion—Doxorubicin—sarcoma	0.00208	0.00434	CcSEcCtD
Loxapine—Confusional state—Thiotepa—sarcoma	0.00207	0.00431	CcSEcCtD
Loxapine—Hypoaesthesia—Etoposide—sarcoma	0.00207	0.0043	CcSEcCtD
Loxapine—ADRA2A—connective tissue—sarcoma	0.00206	0.00472	CbGeAlD
Loxapine—SLC6A3—testis—sarcoma	0.00205	0.00471	CbGeAlD
Loxapine—Agitation—Vincristine—sarcoma	0.00205	0.00427	CcSEcCtD
Loxapine—Vision blurred—Mitoxantrone—sarcoma	0.00205	0.00426	CcSEcCtD
Loxapine—Oedema—Dactinomycin—sarcoma	0.00204	0.00424	CcSEcCtD
Loxapine—HTR2A—embryo—sarcoma	0.00203	0.00467	CbGeAlD
Loxapine—ADRA2C—cardiac atrium—sarcoma	0.00203	0.00467	CbGeAlD
Loxapine—ADRA2C—uterus—sarcoma	0.00202	0.00464	CbGeAlD
Loxapine—Nervous system disorder—Thiotepa—sarcoma	0.00201	0.00419	CcSEcCtD
Loxapine—Thrombocytopenia—Thiotepa—sarcoma	0.00201	0.00419	CcSEcCtD
Loxapine—Tachycardia—Thiotepa—sarcoma	0.002	0.00417	CcSEcCtD
Loxapine—Leukopenia—Vincristine—sarcoma	0.002	0.00416	CcSEcCtD
Loxapine—Thrombocytopenia—Dactinomycin—sarcoma	0.00199	0.00416	CcSEcCtD
Loxapine—Dry eye—Doxorubicin—sarcoma	0.00198	0.00412	CcSEcCtD
Loxapine—ADRA1A—lymphoid tissue—sarcoma	0.00198	0.00454	CbGeAlD
Loxapine—Leukopenia—Mitoxantrone—sarcoma	0.00194	0.00405	CcSEcCtD
Loxapine—Convulsion—Vincristine—sarcoma	0.00193	0.00403	CcSEcCtD
Loxapine—HTR7—tendon—sarcoma	0.00193	0.00443	CbGeAlD
Loxapine—Hypertension—Vincristine—sarcoma	0.00193	0.00401	CcSEcCtD
Loxapine—Photosensitivity—Epirubicin—sarcoma	0.00192	0.00399	CcSEcCtD
Loxapine—HRH1—smooth muscle tissue—sarcoma	0.00192	0.0044	CbGeAlD
Loxapine—Cough—Mitoxantrone—sarcoma	0.0019	0.00395	CcSEcCtD
Loxapine—Angiopathy—Etoposide—sarcoma	0.00188	0.00392	CcSEcCtD
Loxapine—Convulsion—Mitoxantrone—sarcoma	0.00188	0.00392	CcSEcCtD
Loxapine—Hypertension—Mitoxantrone—sarcoma	0.00188	0.00391	CcSEcCtD
Loxapine—Mediastinal disorder—Etoposide—sarcoma	0.00187	0.0039	CcSEcCtD
Loxapine—Chest pain—Mitoxantrone—sarcoma	0.00185	0.00385	CcSEcCtD
Loxapine—Paraesthesia—Thiotepa—sarcoma	0.00184	0.00384	CcSEcCtD
Loxapine—Alopecia—Etoposide—sarcoma	0.00183	0.00382	CcSEcCtD
Loxapine—Somnolence—Thiotepa—sarcoma	0.00183	0.0038	CcSEcCtD
Loxapine—Oedema—Vincristine—sarcoma	0.00182	0.00379	CcSEcCtD
Loxapine—HTR2A—hematopoietic system—sarcoma	0.00182	0.00417	CbGeAlD
Loxapine—Confusional state—Mitoxantrone—sarcoma	0.00179	0.00372	CcSEcCtD
Loxapine—Nervous system disorder—Vincristine—sarcoma	0.00179	0.00372	CcSEcCtD
Loxapine—Thrombocytopenia—Vincristine—sarcoma	0.00178	0.00371	CcSEcCtD
Loxapine—Oedema—Mitoxantrone—sarcoma	0.00177	0.00369	CcSEcCtD
Loxapine—Gastrointestinal disorder—Thiotepa—sarcoma	0.00177	0.00369	CcSEcCtD
Loxapine—Photosensitivity—Doxorubicin—sarcoma	0.00177	0.00369	CcSEcCtD
Loxapine—ADRA2C—tendon—sarcoma	0.00177	0.00407	CbGeAlD
Loxapine—Fatigue—Thiotepa—sarcoma	0.00177	0.00369	CcSEcCtD
Loxapine—Dysgeusia—Etoposide—sarcoma	0.00177	0.00369	CcSEcCtD
Loxapine—Fatigue—Dactinomycin—sarcoma	0.00176	0.00366	CcSEcCtD
Loxapine—Constipation—Thiotepa—sarcoma	0.00176	0.00366	CcSEcCtD
Loxapine—HTR2A—connective tissue—sarcoma	0.00175	0.00402	CbGeAlD
Loxapine—Shock—Mitoxantrone—sarcoma	0.00174	0.00363	CcSEcCtD
Loxapine—Muscle spasms—Etoposide—sarcoma	0.00174	0.00362	CcSEcCtD
Loxapine—Thrombocytopenia—Mitoxantrone—sarcoma	0.00174	0.00362	CcSEcCtD
Loxapine—Tachycardia—Mitoxantrone—sarcoma	0.00173	0.0036	CcSEcCtD
Loxapine—Cerebrovascular accident—Epirubicin—sarcoma	0.00172	0.00358	CcSEcCtD
Loxapine—Hypotension—Vincristine—sarcoma	0.0017	0.00354	CcSEcCtD
Loxapine—Feeling abnormal—Thiotepa—sarcoma	0.00169	0.00352	CcSEcCtD
Loxapine—Feeling abnormal—Dactinomycin—sarcoma	0.00168	0.0035	CcSEcCtD
Loxapine—CHRM3—testis—sarcoma	0.00168	0.00385	CbGeAlD
Loxapine—Hypotension—Mitoxantrone—sarcoma	0.00166	0.00345	CcSEcCtD
Loxapine—SLC6A2—testis—sarcoma	0.00166	0.0038	CbGeAlD
Loxapine—Insomnia—Vincristine—sarcoma	0.00165	0.00343	CcSEcCtD
Loxapine—Paraesthesia—Vincristine—sarcoma	0.00163	0.00341	CcSEcCtD
Loxapine—ADRA2A—cardiac atrium—sarcoma	0.00162	0.00372	CbGeAlD
Loxapine—Leukopenia—Etoposide—sarcoma	0.00162	0.00337	CcSEcCtD
Loxapine—ADRA2A—uterus—sarcoma	0.00161	0.0037	CbGeAlD
Loxapine—HTR2A—smooth muscle tissue—sarcoma	0.0016	0.00367	CbGeAlD
Loxapine—HTR7—testis—sarcoma	0.0016	0.00367	CbGeAlD
Loxapine—Paraesthesia—Mitoxantrone—sarcoma	0.00159	0.00332	CcSEcCtD
Loxapine—Loss of consciousness—Etoposide—sarcoma	0.00159	0.00331	CcSEcCtD
Loxapine—Cerebrovascular accident—Doxorubicin—sarcoma	0.00159	0.00331	CcSEcCtD
Loxapine—Dyspnoea—Mitoxantrone—sarcoma	0.00158	0.00329	CcSEcCtD
Loxapine—Cough—Etoposide—sarcoma	0.00158	0.00328	CcSEcCtD
Loxapine—Somnolence—Mitoxantrone—sarcoma	0.00158	0.00328	CcSEcCtD
Loxapine—Gastrointestinal disorder—Vincristine—sarcoma	0.00157	0.00327	CcSEcCtD
Loxapine—Fatigue—Vincristine—sarcoma	0.00157	0.00327	CcSEcCtD
Loxapine—Convulsion—Etoposide—sarcoma	0.00157	0.00326	CcSEcCtD
Loxapine—Hypertension—Etoposide—sarcoma	0.00156	0.00325	CcSEcCtD
Loxapine—Constipation—Vincristine—sarcoma	0.00156	0.00324	CcSEcCtD
Loxapine—Chest pain—Etoposide—sarcoma	0.00154	0.0032	CcSEcCtD
Loxapine—Orthostatic hypotension—Epirubicin—sarcoma	0.00154	0.0032	CcSEcCtD
Loxapine—Fatigue—Mitoxantrone—sarcoma	0.00153	0.00318	CcSEcCtD
Loxapine—Constipation—Mitoxantrone—sarcoma	0.00152	0.00316	CcSEcCtD
Loxapine—Hypersensitivity—Thiotepa—sarcoma	0.00151	0.00315	CcSEcCtD
Loxapine—DRD2—testis—sarcoma	0.00151	0.00347	CbGeAlD
Loxapine—HTR7—liver—sarcoma	0.00151	0.00346	CbGeAlD
Loxapine—Hypersensitivity—Dactinomycin—sarcoma	0.0015	0.00313	CcSEcCtD
Loxapine—Confusional state—Etoposide—sarcoma	0.00149	0.0031	CcSEcCtD
Loxapine—Asthenia—Thiotepa—sarcoma	0.00147	0.00307	CcSEcCtD
Loxapine—ADRA2C—testis—sarcoma	0.00147	0.00337	CbGeAlD
Loxapine—Asthenia—Dactinomycin—sarcoma	0.00146	0.00305	CcSEcCtD
Loxapine—Feeling abnormal—Mitoxantrone—sarcoma	0.00146	0.00304	CcSEcCtD
Loxapine—ADRA1A—liver—sarcoma	0.00146	0.00334	CbGeAlD
Loxapine—Dysphagia—Epirubicin—sarcoma	0.00145	0.00303	CcSEcCtD
Loxapine—Pruritus—Thiotepa—sarcoma	0.00145	0.00303	CcSEcCtD
Loxapine—Thrombocytopenia—Etoposide—sarcoma	0.00144	0.00301	CcSEcCtD
Loxapine—Tachycardia—Etoposide—sarcoma	0.00144	0.003	CcSEcCtD
Loxapine—HRH1—tendon—sarcoma	0.00144	0.0033	CbGeAlD
Loxapine—Orthostatic hypotension—Doxorubicin—sarcoma	0.00142	0.00296	CcSEcCtD
Loxapine—ADRA2A—tendon—sarcoma	0.00141	0.00325	CbGeAlD
Loxapine—ADRA2C—liver—sarcoma	0.00139	0.00318	CbGeAlD
Loxapine—Hypotension—Etoposide—sarcoma	0.00138	0.00287	CcSEcCtD
Loxapine—Dizziness—Thiotepa—sarcoma	0.00136	0.00283	CcSEcCtD
Loxapine—Dysphagia—Doxorubicin—sarcoma	0.00134	0.0028	CcSEcCtD
Loxapine—Hypersensitivity—Vincristine—sarcoma	0.00134	0.00279	CcSEcCtD
Loxapine—Photosensitivity reaction—Epirubicin—sarcoma	0.00133	0.00276	CcSEcCtD
Loxapine—Paraesthesia—Etoposide—sarcoma	0.00132	0.00276	CcSEcCtD
Loxapine—Weight increased—Epirubicin—sarcoma	0.00132	0.00276	CcSEcCtD
Loxapine—Weight decreased—Epirubicin—sarcoma	0.00132	0.00274	CcSEcCtD
Loxapine—Dyspnoea—Etoposide—sarcoma	0.00131	0.00274	CcSEcCtD
Loxapine—Somnolence—Etoposide—sarcoma	0.00131	0.00273	CcSEcCtD
Loxapine—Hypersensitivity—Mitoxantrone—sarcoma	0.00131	0.00272	CcSEcCtD
Loxapine—Asthenia—Vincristine—sarcoma	0.00131	0.00272	CcSEcCtD
Loxapine—Vomiting—Thiotepa—sarcoma	0.00131	0.00272	CcSEcCtD
Loxapine—Drowsiness—Epirubicin—sarcoma	0.0013	0.0027	CcSEcCtD
Loxapine—Vomiting—Dactinomycin—sarcoma	0.0013	0.0027	CcSEcCtD
Loxapine—Rash—Thiotepa—sarcoma	0.00129	0.0027	CcSEcCtD
Loxapine—Dermatitis—Thiotepa—sarcoma	0.00129	0.00269	CcSEcCtD
Loxapine—Headache—Thiotepa—sarcoma	0.00129	0.00268	CcSEcCtD
Loxapine—Rash—Dactinomycin—sarcoma	0.00128	0.00268	CcSEcCtD
Loxapine—Renal failure—Epirubicin—sarcoma	0.00127	0.00265	CcSEcCtD
Loxapine—Gastrointestinal disorder—Etoposide—sarcoma	0.00127	0.00265	CcSEcCtD
Loxapine—Asthenia—Mitoxantrone—sarcoma	0.00127	0.00265	CcSEcCtD
Loxapine—Fatigue—Etoposide—sarcoma	0.00127	0.00265	CcSEcCtD
Loxapine—Jaundice—Epirubicin—sarcoma	0.00126	0.00263	CcSEcCtD
Loxapine—Constipation—Etoposide—sarcoma	0.00126	0.00263	CcSEcCtD
Loxapine—Photosensitivity reaction—Doxorubicin—sarcoma	0.00123	0.00256	CcSEcCtD
Loxapine—Weight increased—Doxorubicin—sarcoma	0.00122	0.00255	CcSEcCtD
Loxapine—Nausea—Thiotepa—sarcoma	0.00122	0.00254	CcSEcCtD
Loxapine—Weight decreased—Doxorubicin—sarcoma	0.00122	0.00253	CcSEcCtD
Loxapine—Feeling abnormal—Etoposide—sarcoma	0.00122	0.00253	CcSEcCtD
Loxapine—Nausea—Dactinomycin—sarcoma	0.00121	0.00252	CcSEcCtD
Loxapine—Agranulocytosis—Epirubicin—sarcoma	0.00121	0.00252	CcSEcCtD
Loxapine—Dizziness—Vincristine—sarcoma	0.0012	0.00251	CcSEcCtD
Loxapine—HTR2A—tendon—sarcoma	0.0012	0.00276	CbGeAlD
Loxapine—SLC6A2—lymph node—sarcoma	0.0012	0.00276	CbGeAlD
Loxapine—Drowsiness—Doxorubicin—sarcoma	0.0012	0.0025	CcSEcCtD
Loxapine—HRH1—testis—sarcoma	0.00119	0.00274	CbGeAlD
Loxapine—Renal failure—Doxorubicin—sarcoma	0.00118	0.00246	CcSEcCtD
Loxapine—ADRA2A—testis—sarcoma	0.00117	0.00269	CbGeAlD
Loxapine—Jaundice—Doxorubicin—sarcoma	0.00117	0.00243	CcSEcCtD
Loxapine—Hepatitis—Epirubicin—sarcoma	0.00116	0.00242	CcSEcCtD
Loxapine—Hypoaesthesia—Epirubicin—sarcoma	0.00116	0.00241	CcSEcCtD
Loxapine—Vomiting—Vincristine—sarcoma	0.00116	0.00241	CcSEcCtD
Loxapine—Rash—Vincristine—sarcoma	0.00115	0.00239	CcSEcCtD
Loxapine—Dermatitis—Vincristine—sarcoma	0.00115	0.00239	CcSEcCtD
Loxapine—Headache—Vincristine—sarcoma	0.00114	0.00238	CcSEcCtD
Loxapine—Vomiting—Mitoxantrone—sarcoma	0.00113	0.00235	CcSEcCtD
Loxapine—Agranulocytosis—Doxorubicin—sarcoma	0.00112	0.00233	CcSEcCtD
Loxapine—Rash—Mitoxantrone—sarcoma	0.00112	0.00233	CcSEcCtD
Loxapine—Dermatitis—Mitoxantrone—sarcoma	0.00112	0.00233	CcSEcCtD
Loxapine—Headache—Mitoxantrone—sarcoma	0.00111	0.00231	CcSEcCtD
Loxapine—Hypersensitivity—Etoposide—sarcoma	0.00109	0.00226	CcSEcCtD
Loxapine—Nausea—Vincristine—sarcoma	0.00108	0.00225	CcSEcCtD
Loxapine—Hepatitis—Doxorubicin—sarcoma	0.00108	0.00224	CcSEcCtD
Loxapine—Hypoaesthesia—Doxorubicin—sarcoma	0.00107	0.00223	CcSEcCtD
Loxapine—ADRA2C—lymph node—sarcoma	0.00106	0.00244	CbGeAlD
Loxapine—Asthenia—Etoposide—sarcoma	0.00106	0.0022	CcSEcCtD
Loxapine—Angiopathy—Epirubicin—sarcoma	0.00106	0.0022	CcSEcCtD
Loxapine—Nausea—Mitoxantrone—sarcoma	0.00105	0.00219	CcSEcCtD
Loxapine—Mediastinal disorder—Epirubicin—sarcoma	0.00105	0.00218	CcSEcCtD
Loxapine—Pruritus—Etoposide—sarcoma	0.00104	0.00217	CcSEcCtD
Loxapine—Alopecia—Epirubicin—sarcoma	0.00103	0.00214	CcSEcCtD
Loxapine—HTR2A—testis—sarcoma	0.000995	0.00229	CbGeAlD
Loxapine—Tension—Epirubicin—sarcoma	0.000994	0.00207	CcSEcCtD
Loxapine—Dysgeusia—Epirubicin—sarcoma	0.000992	0.00207	CcSEcCtD
Loxapine—Angiopathy—Doxorubicin—sarcoma	0.000977	0.00203	CcSEcCtD
Loxapine—Dizziness—Etoposide—sarcoma	0.000975	0.00203	CcSEcCtD
Loxapine—Muscle spasms—Epirubicin—sarcoma	0.000974	0.00203	CcSEcCtD
Loxapine—Mediastinal disorder—Doxorubicin—sarcoma	0.00097	0.00202	CcSEcCtD
Loxapine—Vision blurred—Epirubicin—sarcoma	0.000955	0.00199	CcSEcCtD
Loxapine—Alopecia—Doxorubicin—sarcoma	0.000951	0.00198	CcSEcCtD
Loxapine—HTR2A—liver—sarcoma	0.000941	0.00216	CbGeAlD
Loxapine—Vomiting—Etoposide—sarcoma	0.000938	0.00195	CcSEcCtD
Loxapine—Agitation—Epirubicin—sarcoma	0.000931	0.00194	CcSEcCtD
Loxapine—Rash—Etoposide—sarcoma	0.00093	0.00194	CcSEcCtD
Loxapine—Dermatitis—Etoposide—sarcoma	0.000929	0.00194	CcSEcCtD
Loxapine—Headache—Etoposide—sarcoma	0.000924	0.00192	CcSEcCtD
Loxapine—Tension—Doxorubicin—sarcoma	0.00092	0.00192	CcSEcCtD
Loxapine—Dysgeusia—Doxorubicin—sarcoma	0.000918	0.00191	CcSEcCtD
Loxapine—Syncope—Epirubicin—sarcoma	0.000908	0.00189	CcSEcCtD
Loxapine—Leukopenia—Epirubicin—sarcoma	0.000907	0.00189	CcSEcCtD
Loxapine—Muscle spasms—Doxorubicin—sarcoma	0.000901	0.00188	CcSEcCtD
Loxapine—Loss of consciousness—Epirubicin—sarcoma	0.00089	0.00185	CcSEcCtD
Loxapine—Cough—Epirubicin—sarcoma	0.000884	0.00184	CcSEcCtD
Loxapine—Vision blurred—Doxorubicin—sarcoma	0.000883	0.00184	CcSEcCtD
Loxapine—Convulsion—Epirubicin—sarcoma	0.000878	0.00183	CcSEcCtD
Loxapine—Nausea—Etoposide—sarcoma	0.000876	0.00182	CcSEcCtD
Loxapine—Hypertension—Epirubicin—sarcoma	0.000874	0.00182	CcSEcCtD
Loxapine—HRH1—lymph node—sarcoma	0.000864	0.00198	CbGeAlD
Loxapine—Chest pain—Epirubicin—sarcoma	0.000862	0.0018	CcSEcCtD
Loxapine—Agitation—Doxorubicin—sarcoma	0.000861	0.00179	CcSEcCtD
Loxapine—ADRA2A—lymph node—sarcoma	0.000848	0.00195	CbGeAlD
Loxapine—Dry mouth—Epirubicin—sarcoma	0.000843	0.00176	CcSEcCtD
Loxapine—Syncope—Doxorubicin—sarcoma	0.00084	0.00175	CcSEcCtD
Loxapine—Leukopenia—Doxorubicin—sarcoma	0.000839	0.00175	CcSEcCtD
Loxapine—Confusional state—Epirubicin—sarcoma	0.000833	0.00174	CcSEcCtD
Loxapine—Oedema—Epirubicin—sarcoma	0.000827	0.00172	CcSEcCtD
Loxapine—Loss of consciousness—Doxorubicin—sarcoma	0.000824	0.00172	CcSEcCtD
Loxapine—Cough—Doxorubicin—sarcoma	0.000818	0.0017	CcSEcCtD
Loxapine—Shock—Epirubicin—sarcoma	0.000813	0.00169	CcSEcCtD
Loxapine—Convulsion—Doxorubicin—sarcoma	0.000812	0.00169	CcSEcCtD
Loxapine—Nervous system disorder—Epirubicin—sarcoma	0.000811	0.00169	CcSEcCtD
Loxapine—Thrombocytopenia—Epirubicin—sarcoma	0.000809	0.00169	CcSEcCtD
Loxapine—Hypertension—Doxorubicin—sarcoma	0.000809	0.00169	CcSEcCtD
Loxapine—Tachycardia—Epirubicin—sarcoma	0.000807	0.00168	CcSEcCtD
Loxapine—Chest pain—Doxorubicin—sarcoma	0.000798	0.00166	CcSEcCtD
Loxapine—Dry mouth—Doxorubicin—sarcoma	0.00078	0.00163	CcSEcCtD
Loxapine—Hypotension—Epirubicin—sarcoma	0.000772	0.00161	CcSEcCtD
Loxapine—Confusional state—Doxorubicin—sarcoma	0.000771	0.00161	CcSEcCtD
Loxapine—Oedema—Doxorubicin—sarcoma	0.000765	0.00159	CcSEcCtD
Loxapine—Shock—Doxorubicin—sarcoma	0.000752	0.00157	CcSEcCtD
Loxapine—Nervous system disorder—Doxorubicin—sarcoma	0.00075	0.00156	CcSEcCtD
Loxapine—Thrombocytopenia—Doxorubicin—sarcoma	0.000749	0.00156	CcSEcCtD
Loxapine—Insomnia—Epirubicin—sarcoma	0.000748	0.00156	CcSEcCtD
Loxapine—Tachycardia—Doxorubicin—sarcoma	0.000746	0.00155	CcSEcCtD
Loxapine—Paraesthesia—Epirubicin—sarcoma	0.000742	0.00155	CcSEcCtD
Loxapine—Dyspnoea—Epirubicin—sarcoma	0.000737	0.00154	CcSEcCtD
Loxapine—Somnolence—Epirubicin—sarcoma	0.000735	0.00153	CcSEcCtD
Loxapine—Hypotension—Doxorubicin—sarcoma	0.000715	0.00149	CcSEcCtD
Loxapine—Gastrointestinal disorder—Epirubicin—sarcoma	0.000714	0.00149	CcSEcCtD
Loxapine—Fatigue—Epirubicin—sarcoma	0.000713	0.00148	CcSEcCtD
Loxapine—Constipation—Epirubicin—sarcoma	0.000707	0.00147	CcSEcCtD
Loxapine—Insomnia—Doxorubicin—sarcoma	0.000692	0.00144	CcSEcCtD
Loxapine—Paraesthesia—Doxorubicin—sarcoma	0.000687	0.00143	CcSEcCtD
Loxapine—Dyspnoea—Doxorubicin—sarcoma	0.000682	0.00142	CcSEcCtD
Loxapine—Feeling abnormal—Epirubicin—sarcoma	0.000681	0.00142	CcSEcCtD
Loxapine—Somnolence—Doxorubicin—sarcoma	0.00068	0.00142	CcSEcCtD
Loxapine—Gastrointestinal disorder—Doxorubicin—sarcoma	0.00066	0.00138	CcSEcCtD
Loxapine—Fatigue—Doxorubicin—sarcoma	0.000659	0.00137	CcSEcCtD
Loxapine—Constipation—Doxorubicin—sarcoma	0.000654	0.00136	CcSEcCtD
Loxapine—Feeling abnormal—Doxorubicin—sarcoma	0.00063	0.00131	CcSEcCtD
Loxapine—Hypersensitivity—Epirubicin—sarcoma	0.000609	0.00127	CcSEcCtD
Loxapine—Asthenia—Epirubicin—sarcoma	0.000593	0.00124	CcSEcCtD
Loxapine—Pruritus—Epirubicin—sarcoma	0.000585	0.00122	CcSEcCtD
Loxapine—Hypersensitivity—Doxorubicin—sarcoma	0.000564	0.00117	CcSEcCtD
Loxapine—Asthenia—Doxorubicin—sarcoma	0.000549	0.00114	CcSEcCtD
Loxapine—Dizziness—Epirubicin—sarcoma	0.000547	0.00114	CcSEcCtD
Loxapine—Pruritus—Doxorubicin—sarcoma	0.000541	0.00113	CcSEcCtD
Loxapine—Vomiting—Epirubicin—sarcoma	0.000526	0.00109	CcSEcCtD
Loxapine—Rash—Epirubicin—sarcoma	0.000521	0.00109	CcSEcCtD
Loxapine—Dermatitis—Epirubicin—sarcoma	0.000521	0.00108	CcSEcCtD
Loxapine—Headache—Epirubicin—sarcoma	0.000518	0.00108	CcSEcCtD
Loxapine—Dizziness—Doxorubicin—sarcoma	0.000506	0.00105	CcSEcCtD
Loxapine—Nausea—Epirubicin—sarcoma	0.000491	0.00102	CcSEcCtD
Loxapine—Vomiting—Doxorubicin—sarcoma	0.000486	0.00101	CcSEcCtD
Loxapine—Rash—Doxorubicin—sarcoma	0.000482	0.001	CcSEcCtD
Loxapine—Dermatitis—Doxorubicin—sarcoma	0.000482	0.001	CcSEcCtD
Loxapine—Headache—Doxorubicin—sarcoma	0.000479	0.000998	CcSEcCtD
Loxapine—Nausea—Doxorubicin—sarcoma	0.000454	0.000946	CcSEcCtD
Loxapine—ADRA2A—Signaling Pathways—CREB1—sarcoma	1.47e-05	0.000174	CbGpPWpGaD
Loxapine—HTR2A—Signaling by GPCR—KRAS—sarcoma	1.46e-05	0.000173	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—MYC—sarcoma	1.46e-05	0.000173	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—MYC—sarcoma	1.46e-05	0.000173	CbGpPWpGaD
Loxapine—HRH1—Signaling by GPCR—KRAS—sarcoma	1.46e-05	0.000173	CbGpPWpGaD
Loxapine—CHRM1—Signaling by GPCR—KRAS—sarcoma	1.45e-05	0.000172	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—MYC—sarcoma	1.45e-05	0.000172	CbGpPWpGaD
Loxapine—CHRM3—Signaling by GPCR—KRAS—sarcoma	1.45e-05	0.000172	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—IL2—sarcoma	1.45e-05	0.000171	CbGpPWpGaD
Loxapine—HTR1A—Signaling by GPCR—HRAS—sarcoma	1.44e-05	0.00017	CbGpPWpGaD
Loxapine—CHRM2—Signaling by GPCR—KRAS—sarcoma	1.43e-05	0.00017	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—VEGFA—sarcoma	1.43e-05	0.00017	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—IL2—sarcoma	1.43e-05	0.00017	CbGpPWpGaD
Loxapine—ADRA1A—Signaling by GPCR—KRAS—sarcoma	1.43e-05	0.000169	CbGpPWpGaD
Loxapine—HTR2C—Signaling by GPCR—HRAS—sarcoma	1.43e-05	0.000169	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—EGFR—sarcoma	1.43e-05	0.000169	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—EGFR—sarcoma	1.43e-05	0.000169	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—MYC—sarcoma	1.42e-05	0.000168	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—EGFR—sarcoma	1.42e-05	0.000168	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—NRAS—sarcoma	1.42e-05	0.000168	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—CCND1—sarcoma	1.41e-05	0.000167	CbGpPWpGaD
Loxapine—ADRA2A—Signaling by GPCR—EGFR—sarcoma	1.41e-05	0.000167	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—JUN—sarcoma	1.41e-05	0.000167	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—SRC—sarcoma	1.4e-05	0.000166	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—MYC—sarcoma	1.4e-05	0.000165	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—CCND1—sarcoma	1.4e-05	0.000165	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—CTNNB1—sarcoma	1.4e-05	0.000165	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—JUN—sarcoma	1.39e-05	0.000165	CbGpPWpGaD
Loxapine—ADRA2C—Signaling by GPCR—HRAS—sarcoma	1.39e-05	0.000165	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—EGFR—sarcoma	1.39e-05	0.000164	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—SRC—sarcoma	1.38e-05	0.000164	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—CTNNB1—sarcoma	1.38e-05	0.000164	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—IL2—sarcoma	1.38e-05	0.000164	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—MYC—sarcoma	1.38e-05	0.000163	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—IL2—sarcoma	1.38e-05	0.000163	CbGpPWpGaD
Loxapine—ADRA1B—Signaling by GPCR—HRAS—sarcoma	1.37e-05	0.000162	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—VEGFA—sarcoma	1.37e-05	0.000162	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—EGFR—sarcoma	1.37e-05	0.000162	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—MDM2—sarcoma	1.36e-05	0.000161	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—NRAS—sarcoma	1.35e-05	0.00016	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—KRAS—sarcoma	1.35e-05	0.00016	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—VEGFA—sarcoma	1.35e-05	0.00016	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—KRAS—sarcoma	1.35e-05	0.00016	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—CCND1—sarcoma	1.35e-05	0.00016	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—EGFR—sarcoma	1.35e-05	0.00016	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—JUN—sarcoma	1.35e-05	0.000159	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—CCND1—sarcoma	1.34e-05	0.000159	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—KRAS—sarcoma	1.34e-05	0.000159	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—JUN—sarcoma	1.34e-05	0.000158	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—IL2—sarcoma	1.34e-05	0.000158	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—MDM2—sarcoma	1.34e-05	0.000158	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—CTNNB1—sarcoma	1.34e-05	0.000158	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—MDM2—sarcoma	1.33e-05	0.000158	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—NRAS—sarcoma	1.33e-05	0.000158	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—MDM2—sarcoma	1.33e-05	0.000157	CbGpPWpGaD
Loxapine—ADRA2A—Signaling by GPCR—KRAS—sarcoma	1.33e-05	0.000157	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—CTNNB1—sarcoma	1.33e-05	0.000157	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—MDM2—sarcoma	1.33e-05	0.000157	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—MYC—sarcoma	1.32e-05	0.000156	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—IL2—sarcoma	1.32e-05	0.000156	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—MDM2—sarcoma	1.31e-05	0.000155	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—KRAS—sarcoma	1.31e-05	0.000155	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—MDM2—sarcoma	1.31e-05	0.000155	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—CCND1—sarcoma	1.3e-05	0.000154	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—JUN—sarcoma	1.3e-05	0.000154	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—CTNNB1—sarcoma	1.29e-05	0.000153	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—EGFR—sarcoma	1.29e-05	0.000153	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—KRAS—sarcoma	1.29e-05	0.000153	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—CCND1—sarcoma	1.28e-05	0.000152	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—JUN—sarcoma	1.28e-05	0.000152	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—KRAS—sarcoma	1.27e-05	0.000151	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—CTNNB1—sarcoma	1.27e-05	0.000151	CbGpPWpGaD
Loxapine—DRD2—Signaling by GPCR—HRAS—sarcoma	1.26e-05	0.000149	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—SRC—sarcoma	1.26e-05	0.000149	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—MYC—sarcoma	1.26e-05	0.000149	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—SRC—sarcoma	1.25e-05	0.000148	CbGpPWpGaD
Loxapine—HTR2A—Signaling by GPCR—HRAS—sarcoma	1.24e-05	0.000147	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—MYC—sarcoma	1.24e-05	0.000147	CbGpPWpGaD
Loxapine—HRH1—Signaling by GPCR—HRAS—sarcoma	1.24e-05	0.000147	CbGpPWpGaD
Loxapine—CHRM1—Signaling by GPCR—HRAS—sarcoma	1.24e-05	0.000146	CbGpPWpGaD
Loxapine—CHRM3—Signaling by GPCR—HRAS—sarcoma	1.23e-05	0.000146	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—EGFR—sarcoma	1.23e-05	0.000146	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—VEGFA—sarcoma	1.23e-05	0.000145	CbGpPWpGaD
Loxapine—CHRM2—Signaling by GPCR—HRAS—sarcoma	1.22e-05	0.000144	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—KRAS—sarcoma	1.22e-05	0.000144	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—VEGFA—sarcoma	1.22e-05	0.000144	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—MDM2—sarcoma	1.22e-05	0.000144	CbGpPWpGaD
Loxapine—ADRA1A—Signaling by GPCR—HRAS—sarcoma	1.22e-05	0.000144	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—IL2—sarcoma	1.21e-05	0.000144	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—NRAS—sarcoma	1.21e-05	0.000144	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—EGFR—sarcoma	1.21e-05	0.000144	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—SRC—sarcoma	1.21e-05	0.000143	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—NRAS—sarcoma	1.2e-05	0.000142	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—SRC—sarcoma	1.2e-05	0.000142	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—TP53—sarcoma	1.2e-05	0.000142	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—TP53—sarcoma	1.2e-05	0.000142	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—IL2—sarcoma	1.19e-05	0.000141	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—IL2—sarcoma	1.19e-05	0.000141	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—TP53—sarcoma	1.19e-05	0.000141	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—IL2—sarcoma	1.19e-05	0.000141	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—IL2—sarcoma	1.18e-05	0.00014	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—CCND1—sarcoma	1.18e-05	0.00014	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—JUN—sarcoma	1.18e-05	0.00014	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—VEGFA—sarcoma	1.18e-05	0.000139	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—IL2—sarcoma	1.17e-05	0.000139	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—CTNNB1—sarcoma	1.17e-05	0.000139	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—IL2—sarcoma	1.17e-05	0.000139	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—VEGFA—sarcoma	1.17e-05	0.000138	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—SRC—sarcoma	1.17e-05	0.000138	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—TP53—sarcoma	1.17e-05	0.000138	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—CCND1—sarcoma	1.16e-05	0.000138	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—JUN—sarcoma	1.16e-05	0.000138	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—CCND1—sarcoma	1.16e-05	0.000138	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—KRAS—sarcoma	1.16e-05	0.000138	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—NRAS—sarcoma	1.16e-05	0.000137	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—JUN—sarcoma	1.16e-05	0.000137	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—CCND1—sarcoma	1.16e-05	0.000137	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—JUN—sarcoma	1.16e-05	0.000137	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—NRAS—sarcoma	1.15e-05	0.000137	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—CCND1—sarcoma	1.15e-05	0.000137	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—CTNNB1—sarcoma	1.15e-05	0.000137	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—JUN—sarcoma	1.15e-05	0.000136	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—CTNNB1—sarcoma	1.15e-05	0.000136	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—SRC—sarcoma	1.15e-05	0.000136	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—HRAS—sarcoma	1.15e-05	0.000136	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—CTNNB1—sarcoma	1.15e-05	0.000136	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—TP53—sarcoma	1.15e-05	0.000136	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—KRAS—sarcoma	1.15e-05	0.000136	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—HRAS—sarcoma	1.15e-05	0.000136	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—CTNNB1—sarcoma	1.14e-05	0.000135	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—CCND1—sarcoma	1.14e-05	0.000135	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—JUN—sarcoma	1.14e-05	0.000135	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—CCND1—sarcoma	1.14e-05	0.000135	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—HRAS—sarcoma	1.14e-05	0.000135	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—JUN—sarcoma	1.14e-05	0.000135	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—VEGFA—sarcoma	1.14e-05	0.000135	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—CTNNB1—sarcoma	1.13e-05	0.000134	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—TP53—sarcoma	1.13e-05	0.000134	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—MYC—sarcoma	1.13e-05	0.000134	CbGpPWpGaD
Loxapine—ADRA2A—Signaling by GPCR—HRAS—sarcoma	1.13e-05	0.000134	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—CTNNB1—sarcoma	1.13e-05	0.000134	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—NRAS—sarcoma	1.12e-05	0.000133	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—MYC—sarcoma	1.12e-05	0.000133	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—VEGFA—sarcoma	1.12e-05	0.000133	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—HRAS—sarcoma	1.11e-05	0.000132	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—EGFR—sarcoma	1.11e-05	0.000131	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—NRAS—sarcoma	1.11e-05	0.000131	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—HRAS—sarcoma	1.1e-05	0.00013	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—EGFR—sarcoma	1.1e-05	0.00013	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—IL2—sarcoma	1.09e-05	0.000129	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—TP53—sarcoma	1.08e-05	0.000128	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—HRAS—sarcoma	1.08e-05	0.000128	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—MYC—sarcoma	1.08e-05	0.000128	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—MYC—sarcoma	1.08e-05	0.000127	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—CCND1—sarcoma	1.06e-05	0.000125	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—SRC—sarcoma	1.06e-05	0.000125	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—EGFR—sarcoma	1.06e-05	0.000125	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—JUN—sarcoma	1.06e-05	0.000125	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—EGFR—sarcoma	1.05e-05	0.000125	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—CTNNB1—sarcoma	1.05e-05	0.000124	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—MYC—sarcoma	1.05e-05	0.000124	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—KRAS—sarcoma	1.04e-05	0.000124	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—SRC—sarcoma	1.04e-05	0.000123	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—SRC—sarcoma	1.04e-05	0.000123	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—SRC—sarcoma	1.04e-05	0.000123	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—HRAS—sarcoma	1.04e-05	0.000123	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—KRAS—sarcoma	1.04e-05	0.000123	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—SRC—sarcoma	1.03e-05	0.000122	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—TP53—sarcoma	1.03e-05	0.000122	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—VEGFA—sarcoma	1.03e-05	0.000122	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—MYC—sarcoma	1.03e-05	0.000122	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—SRC—sarcoma	1.02e-05	0.000121	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—EGFR—sarcoma	1.02e-05	0.000121	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—SRC—sarcoma	1.02e-05	0.000121	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—NRAS—sarcoma	1.02e-05	0.000121	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—TP53—sarcoma	1.02e-05	0.000121	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—VEGFA—sarcoma	1.02e-05	0.00012	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—VEGFA—sarcoma	1.01e-05	0.00012	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—VEGFA—sarcoma	1.01e-05	0.00012	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—EGFR—sarcoma	1.01e-05	0.000119	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—VEGFA—sarcoma	1.01e-05	0.000119	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—NRAS—sarcoma	1e-05	0.000119	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—NRAS—sarcoma	1e-05	0.000118	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—KRAS—sarcoma	9.99e-06	0.000118	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—NRAS—sarcoma	9.98e-06	0.000118	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—VEGFA—sarcoma	9.97e-06	0.000118	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—NRAS—sarcoma	9.94e-06	0.000118	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—VEGFA—sarcoma	9.94e-06	0.000118	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—KRAS—sarcoma	9.94e-06	0.000118	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—HRAS—sarcoma	9.88e-06	0.000117	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—NRAS—sarcoma	9.85e-06	0.000117	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—NRAS—sarcoma	9.82e-06	0.000116	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—HRAS—sarcoma	9.75e-06	0.000115	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—KRAS—sarcoma	9.67e-06	0.000114	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—KRAS—sarcoma	9.52e-06	0.000113	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—MYC—sarcoma	9.49e-06	0.000112	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—SRC—sarcoma	9.48e-06	0.000112	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—MYC—sarcoma	9.34e-06	0.000111	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—MYC—sarcoma	9.32e-06	0.00011	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—MYC—sarcoma	9.29e-06	0.00011	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—EGFR—sarcoma	9.29e-06	0.00011	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—TP53—sarcoma	9.28e-06	0.00011	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—MYC—sarcoma	9.26e-06	0.00011	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—VEGFA—sarcoma	9.24e-06	0.000109	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—TP53—sarcoma	9.2e-06	0.000109	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—MYC—sarcoma	9.17e-06	0.000109	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—MYC—sarcoma	9.15e-06	0.000108	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—EGFR—sarcoma	9.14e-06	0.000108	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—NRAS—sarcoma	9.12e-06	0.000108	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—EGFR—sarcoma	9.12e-06	0.000108	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—EGFR—sarcoma	9.09e-06	0.000108	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—EGFR—sarcoma	9.06e-06	0.000107	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—EGFR—sarcoma	8.97e-06	0.000106	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—EGFR—sarcoma	8.95e-06	0.000106	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—TP53—sarcoma	8.88e-06	0.000105	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—HRAS—sarcoma	8.88e-06	0.000105	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—TP53—sarcoma	8.84e-06	0.000105	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—HRAS—sarcoma	8.8e-06	0.000104	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—KRAS—sarcoma	8.77e-06	0.000104	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—KRAS—sarcoma	8.63e-06	0.000102	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—KRAS—sarcoma	8.61e-06	0.000102	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—TP53—sarcoma	8.59e-06	0.000102	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—KRAS—sarcoma	8.59e-06	0.000102	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—KRAS—sarcoma	8.56e-06	0.000101	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—MYC—sarcoma	8.5e-06	0.000101	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—HRAS—sarcoma	8.49e-06	0.000101	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—KRAS—sarcoma	8.48e-06	0.0001	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—TP53—sarcoma	8.46e-06	0.0001	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—KRAS—sarcoma	8.45e-06	0.0001	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—HRAS—sarcoma	8.45e-06	0.0001	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—EGFR—sarcoma	8.31e-06	9.84e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—HRAS—sarcoma	8.22e-06	9.73e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—HRAS—sarcoma	8.09e-06	9.58e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—KRAS—sarcoma	7.85e-06	9.3e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—TP53—sarcoma	7.8e-06	9.23e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—TP53—sarcoma	7.67e-06	9.08e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—TP53—sarcoma	7.66e-06	9.06e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—TP53—sarcoma	7.63e-06	9.03e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—TP53—sarcoma	7.61e-06	9.01e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—TP53—sarcoma	7.53e-06	8.92e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—TP53—sarcoma	7.51e-06	8.89e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—HRAS—sarcoma	7.46e-06	8.83e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—HRAS—sarcoma	7.34e-06	8.69e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—HRAS—sarcoma	7.32e-06	8.67e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—HRAS—sarcoma	7.3e-06	8.64e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—HRAS—sarcoma	7.28e-06	8.61e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—HRAS—sarcoma	7.2e-06	8.53e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—HRAS—sarcoma	7.18e-06	8.51e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—TP53—sarcoma	6.98e-06	8.26e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—HRAS—sarcoma	6.68e-06	7.9e-05	CbGpPWpGaD
